Therapeutic Thursday: The Case For Staying In Stealth

Investors in Phoenix called China a competitive threat, though one said it is less of one in cell and gene therapy than in other modalities, and urged companies to guard their data. A bill from two Michigan representatives would put licensing deals with Chinese companies under Treasury review.

• Capsul Desk